62 results on '"Vassal, G."'
Search Results
2. Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial
3. Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE
4. Nouveaux médicaments contre les cancers pédiatriques : ce qui doit bouger en Europe
5. Multidisciplinarité et formation des spécialistes à l’oncologie et à l’hématologie maligne pédiatrique
6. Accès aux essais précoces de nouveaux médicaments anticancéreux pour les enfants et les adolescents en France
7. Actualités pharmacologiques – le crizotinib (Xalkori®)
8. 468P Real-world safety of trametinib monotherapy or in combination with dabrafenib in children, adolescents, and young adults with relapsed or refractory low-grade glioma (LGG) and high-grade glioma (HGG)
9. Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the HR-NBL-1/SIOPEN trial
10. Dose-finding designs in pediatric phase I clinical trials: Comparison by simulations in a realistic timeline framework
11. Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy
12. Thérapies ciblées en oncologie pédiatrique : nouvelle approche thérapeutique
13. 061 - INTER-B NHL-RITUX-2010 TRIAL FOR CHILDREN/ADOLESCENTS WITH HIGH-RISK MATURE B-NHL: SAFETY AND EFFICACY IN PATIENTS TREATED WITH RITUXIMAB AND LMB CHEMOTHERAPY
14. 464P Intra-patient (Pt) comparison from larotrectinib (Laro) clinical trials in tropomyosin receptor kinase (TRK) fusion cancer: An expanded dataset
15. European collaboration in trials of new agents for children with cancer
16. Individual dosing of carboplatin based on drug monitoring in children receiving high-dose chemotherapy
17. Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastoma
18. Use of a topoisomerase I inhibitor (irinotecan, CPT-11) in metastatic adrenocortical carcinoma
19. Autorisation de mise sur le marché et information pédiatrique pour les médicaments de chimiothérapie des cancers : état des lieux et propositions
20. Quoi de neuf en oncologie pédiatrique
21. 604TiP ON-TRK: A non-interventional study of larotrectinib in patients with TRK fusion cancer
22. 542P Growth modulation index (GMI) of larotrectinib versus prior systemic treatments for TRK fusion cancer patients
23. 364O - Clinical utility of ctDNA genomic alterations (GA) based on ESMO scale for clinical actionability of molecular targets (ESCAT) in advanced NSCLC
24. 26P - A combination of resistance mechanisms is frequent in non-small cell lung cancer (NSCLC) that progressed to EGFR tyrosine kinase inhibitors (TKIs)
25. 1526P - Multiple synchronous mechanisms may contribute to osimertinib resistance in non-small cell lung cancer (NSCLC) patients: Insights of the MATCH-R study
26. 28TiP - CHECK'UP: A prospective cohort study to identify predictive factors of response and mechanisms of resistance to PD-1 and PD-L1 antagonists
27. 434P - Biomarker-driven access to crizotinib in ALK, MET or ROS1 positive (+) malignancies in adults and children: The French national AcSé program
28. Trajectoires scolaires après un cancer pédiatrique : une contribution à l’hypothèse de la sélection par la santé
29. 440TiP - The Herby Study: a Phase 2 Open-Label, Randomized, Multicenter Study of Bevacizumab-Based Therapy in Pediatric Patients with Newly Diagnosed High-Grade Glioma
30. 347 Efficacy of Dasatinib in Targeting Diffuse Intrinsic Pontine Glioma (DIPG) Specific Pathway Activation in Vitro
31. 253 Anti-tumor Activity of the PLK Inhibitor Volasertib (BI 6727) and the Aurora Kinase Inhibitor BI 811283 in Pediatric Malignancies
32. 205 Development of Metastasis Following Inhibition of VEGFR Pathway in an Orthotopic Neuroblastoma Model
33. La biologie moléculaire des gliomes infiltrants du tronc de l’enfant : vers une thérapeutique ciblée ?
34. Interaction méthotrexate–ciprofloxacine : à propos de deux cas d’intoxication sévère
35. 82 How to select a new drug in paediatric oncology
36. 596 POSTER The topoisomerase I inhibitor gimatecan exhibits synergistic activity with temozolomide and tyrosine kinase inhibitors in malignant glioma xenografts
37. 562 POSTER The anti-insulin-like growth factor I receptor antibody EM164 (murine AVE1642) enhances anti-tumor activity of temozolomide against neuroblastoma cell lines and xenografts
38. 248 ORAL Notch pathway: a potential new target for the treatment of paediatric ependymomas
39. 193 POSTER Preclinical evaluation of the marine compound PM00104 within the ITCC pediatric tumor cell line panel in vitro and in vivo
40. 181 POSTER Evaluation of the marine compound PM02734 against a pediatric tumor cell line panel by ITCC preclinical drug evaluation program
41. 15 INVITED Early drug development in the childrens' clinics in Europe
42. 13 INVITED KidsCancerKinome: a EU-FP6 project for preclinical kinase inhibitor evaluation as a tool to prioritize compounds for paediatric development
43. 8 INVITED KidsCancerKinome; Looking for new targets in paediatric cancers
44. Identification de nouveaux gènes candidats sur le chromosome 9Q33-34 impliqués dans la progression des épendymomes de l'enfant
45. 248/249 INVITED Clinical phase I-II and pharmacokinetic study of plitidepsin in children with malignant tumors
46. 244 INVITED ITTC: a European biology and clinical research network for new drug development for children with cancer within the new European Pediatric Medicine Regulation
47. 246 INVITED Imatinib mesylate in recurrent solid tumours expressing KIT or PDGFR (phase II)
48. CO32 SFRP Evaluation des recepteurs de la famille ERBP comme cible therapeutique dans les ependymones de l'enfant
49. Sauvetage de l'intoxication au méthotrexate par la carboxypeptidase G2 : à propos d'un cas
50. Aspects pédiatriques de la toxicité cardiaque des anthracyclines et implications pratiques pour sa prévention
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.